Teva Pharmaceutical Industries Limited Operating Cash Flow for the year ending December 31, 2024: USD 1.25 B

Teva Pharmaceutical Industries Limited Operating Cash Flow is USD 1.25 B for the year ending December 31, 2024, a -8.85% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Teva Pharmaceutical Industries Limited Operating Cash Flow for the year ending December 31, 2023 was USD 1.37 B, a -13.96% change year over year.
  • Teva Pharmaceutical Industries Limited Operating Cash Flow for the year ending December 31, 2022 was USD 1.59 B, a 99.25% change year over year.
  • Teva Pharmaceutical Industries Limited Operating Cash Flow for the year ending December 31, 2021 was USD 798.00 M, a -34.38% change year over year.
  • Teva Pharmaceutical Industries Limited Operating Cash Flow for the year ending December 31, 2020 was USD 1.22 B, a 126.02% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities